Literature DB >> 1347705

Lack of association between an RFLP near the D2 dopamine receptor gene and severe alcoholism.

E Turner1, J Ewing, P Shilling, T L Smith, M Irwin, M Schuckit, J R Kelsoe.   

Abstract

Blum et al (1990) have recently examined a restriction fragment length polymorphism (RFLP) detected by TaqI RFLP to the dopamine D2 receptor gene (DRD2) in deceased alcoholics and nonalcoholics, and reported an association between alcoholism and the A1 allele. Subsequent studies, however, by other investigators have failed to confirm this. We have examined the DRD2 TaqI RFLP in 47 living Caucasian males with severe alcoholism. All alcoholic subjects were thoroughly characterized by a structured interview, and met DSM-III-R criteria for alcohol dependence. Only 9/47 (19%) (1990) of these alcoholics had the AI allele compared to 14/22 (64%) reported by Blum et al. This rate was not significantly different from the rates reported in control populations by Blum et al (1990), CEPH, or Bolos et al (1990), and differed only slightly from those reported by Grandy et al (1990). Alcoholics selected for severe medical complications also displayed a similar rate. Our data do not support an association between alcoholism and the D2 dopamine receptor gene in this population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347705     DOI: 10.1016/0006-3223(92)90052-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  14 in total

1.  Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Rajendra D Badgaiyan; Tomas Palomo; Mark S Gold
Journal:  Med Hypotheses       Date:  2014-02-26       Impact factor: 1.538

2.  The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems.

Authors:  Jacquelyn L Meyers; Emma Nyman; Anu Loukola; Richard J Rose; Jaakko Kaprio; Danielle M Dick
Journal:  Addict Biol       Date:  2012-09-12       Impact factor: 4.280

3.  Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles.

Authors:  S J Peroutka; S C Price; T L Wilhoit; K W Jones
Journal:  Mol Med       Date:  1998-01       Impact factor: 6.354

Review 4.  The next challenge for psychiatric genetics: characterizing the risk associated with identified genes.

Authors:  Danielle M Dick; Richard J Rose; Jaakko Kaprio
Journal:  Ann Clin Psychiatry       Date:  2006 Oct-Dec       Impact factor: 1.567

Review 5.  Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence.

Authors:  M Virkkunen; D Goldman; D A Nielsen; M Linnoila
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

6.  Linkage analysis versus association analysis: distinguishing between two models that explain disease-marker associations.

Authors:  S E Hodge
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

7.  Dopaminergic mutations: within-family association and linkage in multiplex alcohol dependence families.

Authors:  Shirley Y Hill; Eric K Hoffman; Nicholas Zezza; Anbupalam Thalamuthu; Daniel E Weeks; Abigail G Matthews; Indranil Mukhopadhyay
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-06-05       Impact factor: 3.568

8.  Dopamine D2-receptor gene polymorphisms in Scandinavian chronic alcoholics.

Authors:  T Geijer; J Neiman; U Rydberg; A Gyllander; E Jönsson; G Sedvall; P Valverius; L Terenius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 9.  The D2 dopamine receptor gene: a review of association studies in alcoholism.

Authors:  E P Noble
Journal:  Behav Genet       Date:  1993-03       Impact factor: 2.805

10.  The ANKK1 kinase gene and psychiatric disorders.

Authors:  Guillermo Ponce; Rocío Pérez-González; María Aragüés; Tomás Palomo; Roberto Rodríguez-Jiménez; Miguel Angel Jiménez-Arriero; Janet Hoenicka
Journal:  Neurotox Res       Date:  2009-04-07       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.